Other studies have also demonstrated that miR-19a and miR-19b directly target SOCS-1 (suppressor of cytokine signaling 1), a gene that shows loss of function in multiple myeloma, and inhibits IL-6 growth signaling[24]. The gene discussed is SOCS1; the disease is plasma cell myeloma.